Complete Genomics, Inc. (GNOM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

2071 STIERLIN COURT MOUNTAIN VIEW, CA 94043

A life sciences company that has developed and commercialized an innovative DNA sequencing platform

Are you looking for these stocks instead?

View SEC Filings from GNOM instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GNOM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GNOM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RAFFEL KEITH SVP & CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2013-03-14 0

DRMANAC RADOJE T CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2013-03-14 0

REID CLIFFORD A PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2013-03-14 0

WAITE CHARLES P JR

  • Director
No longer subject to file 2013-03-14 0

BANSAL AJAY SVP & CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2013-03-14 0

OVP VENTURE PARTNERS VI LP

  • 10% Owner
No longer subject to file 2013-03-14 0

HOMAN ARTHUR W SVP, GEN. COUNSEL & SECRETARY

  • Officer
No longer subject to file 2013-03-14 0

CASKEY C THOMAS

  • Director
No longer subject to file 2013-03-14 0

SHUSTER LEWIS

  • Director
No longer subject to file 2013-03-14 0

WALL ROBERT T

  • Director
No longer subject to file 2013-03-14 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP III LLC

ISALY SAMUEL D

  • 10% Owner
No longer subject to file 2012-07-11 0

SENYEI ANDREW E

  • Director
  • 10% Owner
0 2012-06-22 0

MARTIN BRUCE K SVP, PRODUCT DEVELOPMENT

  • Officer
0 2012-04-02 0

SUTHERLAND MARK J. SVP, BUSINESS DEVELOPMENT

  • Officer
No longer subject to file 2012-02-14 0

OVP VENTURE PARTNERS VI LP

WAITE CHARLES P JR

  • Director
  • 10% Owner
2,457,629 2011-12-14 0

ENTERPRISE PARTNERS MANAGEMENT LLC

  • 10% Owner
201,043 2011-12-14 0

DONDERO JAMES D

HIGHLAND CAPITAL MANAGEMENT LP

HIGHLAND CAPITAL MANAGEMENT SERVICES, INC.

STRAND ADVISORS, INC.

  • 10% Owner
2,505,489 2011-05-26 0

BARKAS ALEXANDER E

  • Director
  • 10% Owner
2,994,358 2010-11-30 0

GORDON CARL L

  • Director
0 2010-11-30 0

ENTERPRISE PARTNERS V L P

  • 10% Owner
667,068 2010-11-16 0

ENTERPRISE PARTNERS VI LP

  • 10% Owner
2,052,418 2010-11-16 0

HIGHLAND CAPITAL MANAGEMENT LP

STRAND ADVISORS, INC.

DONDERO JAMES D

  • 10% Owner
2,494,866 2010-11-16 0

PROSPECT VENTURE PARTNERS III L P

PROSPECT MANAGEMENT CO. III, L.L.C.

  • 10% Owner
5,249,841 2010-11-16 0

ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP

ESSEX WOODLANDS HEALTH VENTURES FUND VIII-A LP

ESSEX WOODLANDS HEALTH VENTURES FUND VIII-B LP

  • 10% Owner
4,156,269 2010-11-16 0

ORBIMED ADVISORS LLC

  • 10% Owner
4,156,270 2010-11-16 0

OVP VENTURE PARTNERS VI LP

OVP VI ENTREPRENEURS FUND LP

  • 10% Owner
32,079 2010-11-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments